Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
Hepatology (Baltimore, Md.)
|
July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
JAMA Oncology
|
July 18, 2024
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
The Lancet. Digital Health
|
February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
Mathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan
Chin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Journal of Hepatology
|
November 16, 2023
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, et al.
Science (New York, N.Y.)
|
April 14, 2007
Evolutionary and biomedical insights from the rhesus macaque genome
, Richard A Gibbs, Jeffrey Rogers, et al.
Nature
|
December 6, 2002
Initial sequencing and comparative analysis of the mouse genome
, Robert H Waterston, Kerstin Lindblad-Toh, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
Hepatology (Baltimore, Md.)
|
July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
JAMA Oncology
|
July 18, 2024
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
The Lancet. Digital Health
|
February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
Mathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan
Chin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Journal of Hepatology
|
November 16, 2023
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, et al.
Science (New York, N.Y.)
|
April 14, 2007
Evolutionary and biomedical insights from the rhesus macaque genome
, Richard A Gibbs, Jeffrey Rogers, et al.
Nature
|
December 6, 2002
Initial sequencing and comparative analysis of the mouse genome
, Robert H Waterston, Kerstin Lindblad-Toh, et al.
Page
of 12